|
Assigned to: Bankruptcy Judge Thomas M Horan Chapter 11 Voluntary Asset |
|
Debtor BioXcel Therapeutics, Inc.
555 Long Wharf Drive 12th Floor New Haven, CT 06511 NEW HAVEN-CT Tax ID / EIN: XX-XXXXXXX |
represented by |
Sean Matthew Beach
Young, Conaway, Stargatt & Taylor 1000 North King Street Wilmington, DE 19801 302-571-6600 Fax : 302-576-3281 Email: [email protected] Jared W Kochenash
Young Conaway Stargatt & Taylor, LLP Rodney Square 1000 North King Street Wilmington, DE 19801 302-571-6600 Email: [email protected] Jeremiah P. Ledwidge
COOLEY LLP 55 Hudson Yards New York, NY 10001 212-479-6773 Email: [email protected] Michael S. Neumeister
Cooley LLP 350 South Grand Avenue Suite 900 Los Angeles, CA 90071 (213)561-3250 Email: [email protected] Benjamin J. Thomson
COOLEY LLP 110 N. Wacker Drive, Suite 4200 Chicago, IL 60606 312) 881-6396 Email: [email protected] Eric E. Walker
Cooley LLP 110 North Wacker Drive Suite 4200 Chicago, IL 60606-1511 312-881-6375 Fax : 312-881-6598 Email: [email protected] |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
represented by |
Benjamin A. Hackman
Office of the United States Trustee 844 King Street Suite 2207 Wilmington, DE 19801 302-573-6491 Fax : 302-573-6497 Email: [email protected] |
Claims Agent Stretto
www.stretto.com 410 Exchange, Ste 100 Irvine, CA 92602 855-812-6112 |
| |
Transcriber Reliable Companies
Attn: Gene Matthews 1007 North Orange Street Suite 110 Wilmington, DE 19801 302-654-8080 |
| Date Filed | # | Docket Text |
|---|---|---|
| 10/01/2026 | 204 | Docket Text Notice of Certificate/Affidavit of Publication re: Publication of the Wall Street Journal Regarding the Notice of Deadlines for Filing Proofs of Claim (Including for Administrative Expense Claims Arising Under Section 503(b)(9) of the Bankruptcy Code) (General Bar Date Is October 23, 2026 at 5:00 p.m. (Prevailing Eastern Time)). Filed by Stretto. (Betance, Sheryl) (Entered: 10/01/2026) |
| 10/01/2026 | 203 | Docket Text Agenda of Matters Scheduled for Telephonic Hearing Filed by BioXcel Therapeutics, Inc.. Hearing scheduled for 10/5/2026 at 01:00 PM at US Bankruptcy Court, 824 Market St., 3rd Fl., Courtroom #7, Wilmington, Delaware. (Kochenash, Jared) (Entered: 10/01/2026) |
| 10/01/2026 | 202 | Docket Text Receipt of filing fee for Motion for Relief From Stay (B)( 26-11360-TMH) [motion,mrlfsty] ( 199.00). Receipt Number A12845416, amount $ 199.00. (U.S. Treasury) (Entered: 10/01/2026) |
| 10/01/2026 | 201 | Docket Text Exhibit(s) Witness & Exhibit List Regarding Shareholder Class Plaintiffs Objection to Debtors Motion to Enforce Automatic Stay (related document(s)173) Filed by Tonya Hills and Oklahoma Law Enforcement Retirement System as Class Representatives. (Attachments: # 1 Certificate of Service) (Joyce, Michael) (Entered: 10/01/2026) |
| 10/01/2026 | 200 | Docket Text Objection Shareholder Class Plaintiffs Objection to Debtors Motion to Enforce Automatic Stay (related document(s)173) Filed by Tonya Hills and Oklahoma Law Enforcement Retirement System as Class Representatives (Attachments: # 1 Exhibit # 2 Exhibit # 3 Exhibit # 4 Exhibit # 5 Exhibit # 6 Exhibit # 7 Exhibit # 8 Exhibit # 9 Exhibit # 10 Exhibit # 11 Exhibit # 12 Exhibit # 13 Exhibit # 14 Exhibit # 15 Certificate of Service) (Joyce, Michael) (Entered: 10/01/2026) |
| 09/30/2026 | 199 | Docket Text Motion for Relief from Stay (FEE) - Motion for Entry of Order, Pursuant to Section 362(d)(1) of the Bankruptcy Code, Granting Insurers Relief From the Automatic Stay to Issue Payments Under Insurance Policies. Fee Amount $199. Filed by BioXcel Therapeutics, Inc.. Hearing scheduled for 10/21/2026 at 10:00 AM at US Bankruptcy Court, 824 Market St., 3rd Fl., Courtroom #7, Wilmington, Delaware. Objections due by 10/14/2026. (Attachments: # 1 Notice # 2 Exhibit) (Kochenash, Jared) (Entered: 09/30/2026) |
| 09/30/2026 | 198 | Docket Text Notice of Assumption of Lease/Executory Contract - Notice of Cure Amounts and Potential Assumption and Assignment of Executory Contracts and Unexpired Leases in Connection with Sale of Substantially All Assets (related document(s)179). Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 09/30/2026) |
| 09/30/2026 | 197 | Docket Text Motion to Approve - Motion for an Order (I) Conditionally Approving the Combined Disclosure Statement and Plan for Solicitation Purposes Only; (II) Approving Solicitation and Voting Procedures, Including (A) Fixing the Voting Record Date, (B) Approving the Solicitation Packages and Procedures for Distribution, (C) Approving the Form of the Ballots and Establishing Procedures for Voting, (D) Approving Procedures for Vote Tabulation; and (E) Waiving the Requirement Under the Bankruptcy Rules to Solicit Votes of Holders of Interests; (III) Fixing the Date, Time and Place for the Combined Hearing and the Deadline for Filing Objections Thereto; (IV) Approving the Form And Manner of Notice of The Combined Hearing; and (V) Granting Related Relief Filed by BioXcel Therapeutics, Inc.. Hearing scheduled for 10/21/2026 at 10:00 AM at US Bankruptcy Court, 824 Market St., 3rd Fl., Courtroom #7, Wilmington, Delaware. Objections due by 10/14/2026. (Attachments: # 1 Notice # 2 Exhibit) (Kochenash, Jared) (Entered: 09/30/2026) |
| 09/30/2026 | 196 | Docket Text Chapter 11 Combined Plan & Disclosure Statement Filed by BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 09/30/2026) |
| 09/30/2026 | 195 | Docket Text Exhibit(s) - Debtors' Witness and Exhibit List (related document(s)173) Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 09/30/2026) |